Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2015


Pharmaceutical Microbiology

21 Jan 2015 - 22 Jan 2015 - London, UK



Bookmark and Share


Excellence in the Prevention, Detection and Management of Microorganisms

Set to take place on 21st and 22nd January 2015, the 4th annual event in the sell-out Pharmaceutical Microbiology series will bring together all levels of industry professionals, providing essential insights into the latest advancements in practice and technology, developments in regulation and the global harmonisation of evolving microbiology methods.

Join us as we ask questions such as: What are the best approaches in contamination control? Where does microbiological risk assessment interact with HACCP? How do we develop and manage the sterilisation and validation process? When can we use a scoring system to avoid unnecessary microbiological testing? What are the latest approaches to preventing biofilms? 

Hear presentations from an array of market leaders such as GSK, Genzyme, Abbott, MedImmune and AstraZeneca, address real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. 

TOP KEY SPEAKERS INCLUDE:

  • Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
  • Ruth Daniels, Head of MSAT, Microbiology, Genzyme
  • Sara Gamberini, Molecular Biology Scientist, Merck Serono
  • Hans Noordergraaf, Microbiologist, Abbott Biologicals
  • Thomas Schwartz, Microbiology & Molecular Biology Group Leader, Forschungszentrum Karlsrube Gmbh
  • Tim Eaton, Sterile Manufacturing, Specialist, AstraZeneca
  • Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
  • Phil Duncanson, Director of QC, MedImmune

BUSINESS BENEFITS FOR 2015:

  • Discover the latest in the development and management of sterilisation and validation processes
  • Understand data review and analysis for pharmaceutical microbiology
  • Benefit from listening to developments in bioburden and biofilm control strategies
  • Look in depth at issues of objectionable organism management
  • Hear specialist advice on contamination control and risk assessment to minimise costs and maximise efficiency
  • Share the wisdom of respected consultants and get a regulatory perspective on recent changes and issues under review.

“I have attended the last 2 Microbiology conference and have appreciated that outstanding experts from the pharmaceutical industry, and international academia presented various microbiological aspects with a series of case studies to focus on the practical knowledge, the “know how” which can be directly applied on daily business.  I look forward to attend this new conference in London as it is likely to provide an incredible forum for open discussions with speakers and attendants. - Oliver Chancel, Merial Sas

To download a brochure or to book a place visit: www.pharma-microbiology.com

Alternatively contact the team on Tel +44 (0) 870 9090 711 or email events@smi-online.co.uk 




Further information
Scientific News
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!